Exosome therapy is a relatively new concept, with both challenges and significant opportunities
Exosomes are nanosized vesicles (50-200nm) released naturally by cells. They are important effectors of cell communication. A key mechanism by which cell therapies work is via release and uptake of exosomes.
Some of the properties of exosomes are:
VivaZome is leveraging the best that nature and technology has to offer:
Exosome therapy is a relatively new concept, with both challenges and significant opportunities.
Special challenges with large- scale separation and concentration technology and analytics
No registered exosome therapies
Limited but growing clinical experience with exosomes
Evolving exosome-specific guidance from regulatory agencies
Growing number of industry players
Sophisticated exosome analytic technology for product specification
Treatment for Critical Limb Ischemia costs >US$10 billion per annum in USA alone
USA expenditure for CKD was >US$64billion in 2015
In 2016, stroke was the second largest cause of death globally